Trial Profile
Neuropsychiatric, Neurocognitive And Quality Of Life Outcomes In Patients With Epilepsy Treated With Levetiracetam (Keppra) Verses Older AEDs As First Substitution Monotherapy.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Jul 2019
Price :
$35
*
At a glance
- Drugs Levetiracetam (Primary) ; Carbamazepine; Valproic acid
- Indications Partial epilepsies
- Focus Therapeutic Use
- Acronyms KONQUEST
- 03 Sep 2012 The published results stated the original target enrollment in the study was 150.
- 03 Sep 2012 Status changed from recruiting to completed.
- 03 Sep 2012 The published results stated that patients were enrolled over a 23-month period from Feb 15 2006 to Dec 23 2008